High throughput virtual screening reveals SARS-CoV-2 multi-target binding natural compounds to lead instant therapy for COVID-19 treatment

The present-day world is severely suffering from the recently emerged SARS-CoV-2. The lack of prescribed drugs for the deadly virus has stressed the likely need to identify novel inhibitors to alleviate and stop the pandemic. In the present high throughput virtual screening study, we used in silico...

Descripción completa

Detalles Bibliográficos
Autores principales: Naik, Biswajit, Gupta, Nidhi, Ojha, Rupal, Singh, Satyendra, Prajapati, Vijay Kumar, Prusty, Dhaneswar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7250083/
https://www.ncbi.nlm.nih.gov/pubmed/32470577
http://dx.doi.org/10.1016/j.ijbiomac.2020.05.184

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7250083/
https://www.ncbi.nlm.nih.gov/pubmed/32470577
http://dx.doi.org/10.1016/j.ijbiomac.2020.05.184

Ejemplares similares